Provided by Tiger Trade Technology Pte. Ltd.

Titan Pharmaceuticals

4.61
0.0000
Volume:- -
Turnover:19.91M
Market Cap:6.13M
PE:-1.56
High:4.61
Open:4.61
Low:4.61
Close:4.61
52wk High:5.76
52wk Low:3.03
Shares:1.33M
Float Shares:723.50K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9464
EPS(LYR):-5.2347
ROE:-82.72%
ROA:-44.08%
PB:2.20
PE(LYR):-0.88

Loading ...

Company Profile

Company Name:
Titan Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder. The company was founded in 1991 and is based in South San Francisco, California.